Skip to content

Comparing two medications that is propofol and thiopentone in modified electroconvulsive therapy in patients with psychiatric disorders to keep the patients comfortable during the procedure

A comparative study of propofol and thiopentone for modified electroconvulsive therapy - A randomized controlled study - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099482
Enrollment
80
Registered
2025-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders

Interventions

Intervention1: ADMINISTRATION OF DRUGS : PROPOFOL AND THIOPENTONE: TO STUDY EFFECTIVENESS OF THESE TWO GROUPS IN MODIFIED ECTS BY ADMINISTERING PROPOFOL AT 1 TO 2 MG/KG AS INDUCING AGENT IN ONE GROUP

Sponsors

KANCHANA S KOUSHIK
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA GRADE 1 AND GRADE 2 PATIENTS PATIENTS WITH SCHIZOPHRENIA BIPOLAR AND MAJOR DEPRESSIVE DISORDERS REQUIRING MODIFIED ELECTROCONVULSIVE THERAPY

Exclusion criteria

Exclusion criteria: ASA GRADE 3 AND 4 PATIENTS PATIENTS WITH HISTORY OF ALLERGIC REACTION TO THE STUDY DRUGS RECENT CEREBROVASCULAR ACCIDENTS CARDIOVASCULAR DISORDERS RECENT MYOCARDIAL INFARCTION

Design outcomes

Primary

MeasureTime frame
RECOVERY PERIOD AND DURATION OF CONVULSIONS WITH BOTH GROUPSTimepoint: POST INDUCTION AND POST EMERGENCE

Secondary

MeasureTime frame
TO STUDY EFFECT OF BOTH GROUP DRUGS ON HEART RATE , SYSTOLIC AND DIASTOLIC PRESSURETimepoint: BEFORE INDUCTION , AFTER INDUCTION , POST ECT AT 1MINUTE , 3 MINUTES AND 5 MINUTES

Countries

India

Contacts

Public ContactM G DHORIGOL

KAHER JAWAHARLAL NEHRU MEDICAL COLLEGE

mallappadhorigol@gmail.com9844778096

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026